Tandem Investment Advisors Inc. Buys 1,546 Shares of Intuitive Surgical, Inc. $ISRG

Tandem Investment Advisors Inc. grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 16.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,765 shares of the medical equipment provider’s stock after buying an additional 1,546 shares during the quarter. Tandem Investment Advisors Inc.’s holdings in Intuitive Surgical were worth $6,097,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Holos Integrated Wealth LLC bought a new position in Intuitive Surgical during the 4th quarter worth about $25,000. Newbridge Financial Services Group Inc. lifted its holdings in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares in the last quarter. Greykasell Wealth Strategies Inc. bought a new stake in shares of Intuitive Surgical in the third quarter valued at about $27,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Finally, Caitlin John LLC acquired a new position in shares of Intuitive Surgical during the third quarter worth about $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 119 shares of Intuitive Surgical stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total value of $55,156.50. Following the completion of the transaction, the director owned 120 shares of the company’s stock, valued at $55,620. This trade represents a 49.79% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 5,701 shares of company stock valued at $2,783,807. 0.60% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of brokerages recently issued reports on ISRG. Piper Sandler dropped their target price on Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. Mizuho set a $525.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a report on Monday, April 13th. Bank of America cut their price objective on shares of Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research report on Monday, May 18th. Finally, Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Sunday. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $579.33.

View Our Latest Report on ISRG

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $438.10 on Tuesday. The stock has a market cap of $155.16 billion, a P/E ratio of 53.10, a P/E/G ratio of 3.50 and a beta of 1.51. Intuitive Surgical, Inc. has a 12-month low of $417.74 and a 12-month high of $603.88. The business’s 50 day moving average is $457.79 and its 200-day moving average is $509.66.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm’s revenue was up 23.0% on a year-over-year basis. During the same period last year, the business earned $1.81 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Featured Stories

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.